| 1999 |
FACT complex comprises human SPT16 and SSRP1 proteins, functions as a chromatin-specific transcription elongation factor that interacts with nucleosomes and histone H2A/H2B dimers, and facilitates transcription of chromatin templates in vitro; FACT activity is abrogated by covalent crosslinking of nucleosomal histones, indicating it works by promoting nucleosome disassembly during transcription. |
Biochemical purification, reconstituted in vitro transcription on chromatin templates, nucleosome binding assays, crosslinking experiments |
Nature |
High |
10421373
|
| 2001 |
SSRP1 (as part of FACT) forms a UV-activated kinase complex with CK2 and hSPT16 that phosphorylates p53 at Ser-392; within this complex, FACT alters CK2 specificity such that it selectively phosphorylates p53 over other substrates including casein, and phosphorylation by the complex enhances p53 transcriptional activity. |
Biochemical purification of kinase complex, in vitro kinase assays, co-immunoprecipitation |
Molecular cell |
High |
11239457
|
| 2002 |
SSRP1 and hSPT16 interact with CK2 via non-overlapping domains in vitro and in cells; UV irradiation induces assembly of the CK2/hSPT16/SSRP1 complex, increasing CK2 specificity for p53 Ser-392 phosphorylation over other cellular CK2 substrates. |
In vitro interaction assays, domain mapping, co-immunoprecipitation, in-cell complex assembly after UV irradiation |
The Journal of biological chemistry |
High |
12393879
|
| 2001 |
FACT (SPT16/SSRP1 heterodimer) exhibits affinity and specificity for cisplatin-damaged DNA, recognizing the major 1,2-d(GpG) intrastrand cisplatin adduct; the isolated HMG domain of SSRP1 is sufficient for specific binding to cisplatin-damaged DNA, while SSRP1 alone (without SPT16) fails to form discrete high-affinity complexes, suggesting SPT16 primes SSRP1 for cisplatin-damaged DNA recognition by unveiling its HMG domain. |
Gel mobility shift assays with purified FACT, SSRP1, and isolated HMG domain; comparison of cisplatin-modified vs. unmodified and trans-DDP-modified DNA |
The Journal of biological chemistry |
High |
11344167
|
| 2002 |
SSRP1 functions as a co-activator of the transcriptional activator p63; SSRP1 physically interacts with p63γ in vitro and in cells via SSRP1's central domain and p63's N-terminus, and co-occupies p53-responsive elements at MDM2 and p21 promoters; overexpression of SSRP1 enhances p63γ-dependent transcription, G1 arrest, and apoptosis. |
Co-immunoprecipitation, GST pulldown, luciferase reporter assays, chromatin immunoprecipitation, dominant-negative overexpression |
The EMBO journal |
High |
12374749
|
| 1999 |
CHD1 interacts with SSRP1 in vivo via an amino-terminal segment of CHD1 that does not include the chromodomain; CHD1 and SSRP1 co-localize in mammalian nuclei and at transcriptionally active regions in Drosophila polytene chromosomes. |
Transient transfection with wild-type and mutant CHD1 constructs, immunocytochemical co-localization, in vivo interaction assays |
Chromosoma |
Medium |
10199952
|
| 1999 |
SSRP1 interacts with serum response factor (SRF) through the MADS box of SRF and a basic region of SSRP1 (amino acids 489-542) adjacent to the HMG domain; SSRP1 dramatically increases SRF DNA-binding activity and synergistically activates SRF-dependent promoters without itself binding the CArG box. |
Yeast one-hybrid screen, co-immunoprecipitation in yeast and mammalian cells, domain mapping, DNA binding assays, luciferase reporter assays |
The Journal of biological chemistry |
High |
10336466
|
| 1998 |
SSRP1 (identified as PREIIBF) binds with sequence specificity to the PRE II element of the human embryonic epsilon-globin gene, bends target DNA, and is required for promoter activation in stable erythroid cell lines; recombinant SSRP1 is biochemically identical to the endogenous erythroid PREIIBF. |
cDNA expression cloning, recombinant protein characterization, DNA binding assays, DNA bending assays, stable transfection reporter assays |
Molecular and cellular biology |
High |
9566881
|
| 1995 |
SSRP1 was identified as a protein that interacts specifically with the basic helix-loop-helix/leucine zipper domains of c-Myc. |
Bacterial cDNA expression library screen based on protein-protein interaction with lambda cl repressor fusion proteins |
Nucleic acids research |
Low |
7862532
|
| 2003 |
CK2 phosphorylates SSRP1 at multiple sites in the C-terminal region and within the acidic domain; CK2-mediated phosphorylation of two C-terminal sites causes a conformational change in the HMG box domain region and induces recognition of UV-damaged DNA by SSRP1, whereas non-phosphorylated SSRP1 does not discriminate between UV-damaged and control DNA. |
Acetic acid-urea PAGE, mass spectrometry phosphosite mapping, circular dichroism, DNA binding assays with UV-damaged DNA, yeast complementation assay |
The Journal of biological chemistry |
High |
12571244
|
| 2005 |
CK2 phosphorylates SSRP1 at Ser-510, Ser-657, and Ser-688 in vitro; phosphorylation inhibits the nonspecific DNA-binding activity of both SSRP1 and the FACT complex in vitro; Ser-510 is the most important site for regulation of SSRP1 DNA-binding activity; SSRP1 is phosphorylated in cells specifically in response to UV but not gamma irradiation. |
Serine/threonine-scanning Auto-spot peptide array kinase assay, site-directed mutagenesis, in vitro DNA binding assays, in-cell phosphorylation detection after UV/gamma irradiation |
The Journal of biological chemistry |
High |
15659405
|
| 2003 |
Ssrp1 homozygous null embryos die soon after implantation (day 3.5); preimplantation blastocysts are defective for cell outgrowth and/or survival in vitro; the essential function of Ssrp1 is p53-independent, as crossing into a p53-null background does not rescue the growth/survival defects. |
Gene targeting in mouse embryonic stem cells, germline transmission, blastocyst outgrowth assays, genetic epistasis with p53-null background |
Molecular and cellular biology |
High |
12861016
|
| 2007 |
SSRP1 has both SPT16-dependent and SPT16-independent roles in regulating gene transcription in human cells; SSRP1 and SPT16 are required for progression of elongating RNA pol II on the egr1 gene; a subset of genes regulated by SSRP1 is not affected by Spt16 knockdown. |
siRNA knockdown of SSRP1 or SPT16, spotted microarray analysis of 8308 genes, ChIP for RNA pol II occupancy on specific genes |
The Journal of biological chemistry |
High |
17209051
|
| 2009 |
SSRP1 physically interacts with the HR repair protein Rad54 in vitro and in vivo; SSRP1 inhibits Rad54-promoted branch migration of Holliday junctions in vitro; overexpression of SSRP1 reduces HR frequency while knockdown increases HR events, suggesting SSRP1 suppresses homologous recombination. |
Co-immunoprecipitation, GST pulldown, branch migration assays with purified proteins, hprt recombination assay, Rad51 and H2AX foci quantification |
Journal of cellular biochemistry |
High |
19639603
|
| 2009 |
SSRP1 (as a subunit of FACT) forms complexes with LANA at the minimal replicon (MR) region of KSHV latent origin; siRNA knockdown of SSRP1 significantly decreases LANA-dependent latent DNA replication efficiency, establishing SSRP1 as a cellular factor required for KSHV latent replication. |
Biotinylated DNA pulldown/mass spectrometry to identify origin-binding proteins, co-immunoprecipitation with LANA, siRNA knockdown with replication assay |
Journal of virology |
Medium |
19710137
|
| 2015 |
SSRP1 (as part of FACT) suppresses HIV-1 and HTLV-1 transcription and promotes viral latency; SSRP1 is recruited to the HIV-1 LTR promoter; depletion of SSRP1 de-represses Tat-mediated HIV-1 LTR activity and spontaneously reverses HIV-1 latency in multiple cell models; SSRP1 affects both HIV-1 transcriptional initiation and elongation. |
Functional genomic RNAi screen, luciferase reporter assays, ChIP, siRNA knockdown with HIV-1 replication assays, primary CD4+ T cell latency model |
The Journal of biological chemistry |
High |
26378236
|
| 2015 |
Crystal structure of the SSRP1 middle domain reveals tandem pleckstrin homology (PH) domains (PH1 with an extra conserved βαβ topology); the middle domain participates in DNA binding via a positively charged surface patch; the middle domain does not bind histones. |
X-ray crystallography, pull-down assays for histone binding, DNA binding assays |
Scientific reports |
High |
26687053
|
| 2017 |
SSRP1 is recruited to single-strand DNA breaks (SSBs) in a PARP-dependent manner and is retained at damage sites via N-terminal interactions with XRCC1; SSRP1 (but not SPT16) is critical for cell survival after SSB-inducing damage; SSRP1 is required for chromatin decondensation and histone H2B exchange at SSB sites to prime chromatin for efficient repair. |
Live-cell imaging of SSRP1 recruitment to laser-induced SSBs, co-immunoprecipitation with XRCC1, mutational analysis of N-terminal domain, histone H2B exchange assays (FRAP), clonogenic survival after IR/MMS |
Cancer research |
High |
28416484
|
| 2018 |
Human SSRP1 forms an elongated homodimer in solution; SSRP1 homodimerization and heterodimerization with SPT16 both involve the same PH2 surface region and are mutually exclusive; FACT contains only one molecule of SSRP1; SSRP1 binds both histones H2A-H2B and H3-H4, and disruption of homodimerization decreases histone-binding affinity. |
Analytical ultracentrifugation (AUC), small-angle X-ray scattering (SAXS), isothermal titration calorimetry (ITC), site-directed mutagenesis of PH2 domain |
The Journal of biological chemistry |
High |
29764934
|
| 2006 |
SSRP1 is cleaved during apoptosis by caspase-3 and/or caspase-7 at the DQHD450 site; cleavage generates a truncated chromatin-associated form of FACT; the N-terminal cleavage product is ubiquitylated and degraded through the ubiquitin-proteasome pathway, making SSRP1 degradation during apoptosis a two-step process coupling caspase cleavage and ubiquitin-dependent proteolysis. |
In vitro caspase cleavage assays, site-directed mutagenesis, proteasome inhibitor treatment, ubiquitylation detection, subcellular fractionation |
Cell death and differentiation |
High |
16498457
|
| 2020 |
SSRP1 stimulates replication origin assembly on somatic chromatin in Xenopus laevis by promoting eviction of histone H1 through its N-terminal domain; H1 removal derepresses ORC and MCM chromatin binding; SSRP1 protein decays at mid-blastula transition (MBT), and increasing SSRP1 levels delays MBT while accelerating post-MBT cell cycle speed and embryo development. |
Xenopus laevis cell-free replication system, chromatin assembly/disassembly assays, ORC/MCM chromatin binding assays, domain deletion analysis, developmental timing assays |
Nature communications |
High |
32165637
|
| 2024 |
TRIB3 directly interacts with SSRP1 and USP10, forming a TRIB3/USP10/SSRP1 ternary complex; USP10-mediated deubiquitination stabilizes SSRP1 protein, and TRIB3 enhances this deubiquitinating activity; disruption of this complex with a stapled peptide (SP-A) leads to SSRP1 protein degradation. |
Co-immunoprecipitation, ubiquitination assays, stapled peptide disruption experiments, in vitro and in vivo proliferation assays |
Oncogene |
Medium |
39653795
|
| 2016 |
SSRP1 facilitates the translocation of phospho-Ets-1 from cytoplasm to cell nucleus in nasopharyngeal carcinoma cells, thereby positively regulating Pim-3 expression (which is downstream of Ets-1); SSRP1 knockdown diminishes phospho-Ets-1 nuclear localization without affecting Ets-1 expression or phosphorylation levels. |
siRNA knockdown, western blot, immunocytochemistry for subcellular localization of phospho-Ets-1 |
Biomedicine & pharmacotherapy |
Low |
27525970
|
| 2016 |
SSRP1 is essential for Wnt signaling pathway activity during osteoblast differentiation; SSRP1 depletion in human mesenchymal stem cells decreases Wnt target gene expression and reduces nuclear localization of active β-catenin during osteoblast differentiation. |
siRNA knockdown in human mesenchymal stem cells, RNA-seq transcriptome analysis, immunofluorescence for β-catenin nuclear localization |
Stem cells |
Medium |
27146025
|
| 2024 |
The FACT complex (hSpt16/SSRP1) mediates an interferon-independent antiviral innate immune response (FEAR pathway) by remodeling chromatin to activate expression of the antiviral transcription factor ETS-1; poxvirus A51R proteins antagonize this by tethering SUMOylated hSpt16 to microtubules; VSV M protein promotes proteasome-dependent degradation of SUMOylated hSpt16 to block ETS-1 nuclear import and counter FEAR pathway restriction. |
RNAi depletion, viral replication assays, overexpression of viral antagonists, genetic rescue experiments, FACT inhibitor treatment |
bioRxivpreprint |
Medium |
bio_10.1101_2024.08.22.609092
|